Enoxaparin is used to prevent and treat harmful blood clots. This helps to reduce the risk of a stroke or heart attack.
Dalteparin is an anticoagulant that helps prevent the formation of blood clots.
Dalteparin comes as as a solution (liquid) in vials and prefilled syringes to inject subcutaneously (under the skin). It is usually given once a day, but may be given twice a day for certain conditions.
In 16 June, 2016, after approval from Industry and Commerce department, Qingdao Jiulong Biopharmaceutical Co.